news
Scientists develop powerful technique to study the secrets of nanodomains
A team of UK scientists have harnessed an innovative new method to gain a greater understanding of signalling stations within living cells, called nanodomains.
List view / Grid view
University of Cambridge
news
Advances in PET settle debate over spread of key protein in Alzheimer’s
Advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease...
news
Study shows contrasting cognitive effects of psychiatric drugs
A long-term study has found that low cumulative exposure to benzodiazepine does not affect cognition in schizophrenia...
news
Brain training app improves memory in people with cognitive impairment
A brain training game could help improve the memory of patients in the very earliest stages of dementia, suggests a study.
news
Antibiotic-resistant ‘superbug’ bacteria found at NHS-funded factories
19 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Out of 34 sites tested, 16 were found to be harbouring bacteria resistant to antibiotics, according to the report. Resistance to three major antibiotics...
news
Major global study reveals new hypertension and blood pressure genes
13 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The discoveries include DNA changes in three rare genes that have much larger effects on blood pressure in the population than previously seen, providing new insights into the physiology of hypertension and suggesting new targets for treatment...
article
Spectroscopy In-Depth Focus 2016
In this Spectroscopy In-Depth Focus: The benefits of NIRS in monitoring and controlling a crystallisation process; Pharmaceutical applications of terahertz spectroscopy and imaging; and much more...
news
Double-blind clinical trials fail to capture how personal behaviours influence treatment
11 June 2015 | By Victoria White
Trials fail to measure how a drug’s performance can vary based on patient behaviour, especially if patients change habits in anticipation of treatment...
article
Stem Cells In-Depth Focus 2015
In this free-to-view Stem Cells In-Depth Focus, you can find out how computational ('in silico') methods can help to rationally choose bioactive small molecules to improve stem cell differentiation. The differentiation of pluripotent stem cells to hepatocyte-like cells is the focus of a second interesting article...
news
Genetic screening could improve breast cancer prevention
9 April 2015 | By Victoria White
Genetic screening could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study has shown...
news
AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
9 July 2013 | By AstraZeneca
AstraZeneca enters agreement with University of Cambridge & Cancer Research UK...
news
Scientists identify molecular trigger for Alzheimer’s disease
20 May 2013 | By University of Cambridge
New research establishes nature of malfunction in protein molecules that can lead to onset of dementia...
article
Applications of MRI to controlled drug delivery devices
22 October 2012 | By Mick Mantle, Department of Chemical Engineering & Biotechnology, University of Cambridge
Magnetic resonance imaging (MRI) is a technique that is traditionally used as a diagnostic clinical imaging tool. However, there are now an increasing number of non-medial applications where MRI has seen unrivalled success. One of those areas is in its application to pharmaceutical research. The aim of this article is…
article
The need for proteomic-based biomarkers in the drug development pipeline
10 July 2012 | By Paul C. Guest, Department of Chemical Engineering and Biotechnology, University of Cambridge and Sabine Bahn Department of Chemical Engineering and Biotechnology, University of Cambridge & Department of Neuroscience, Erasmus Medical Centre
Pharmaceutical companies are under increasing pressure to improve their efficiency and returns on drug discovery projects. This is a daunting task considering that the average drug costs approximately one billion US dollars to develop and takes around 12 years from initial discovery to reach the market1. In addition, approximately 70…
news
Cambridge-Elan Centre for Research Innovation and Drug Discovery launched
28 November 2011 | By F T I Consulting
World’s leading researchers work together on therapeutic advances in neuroscience...
